SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001808665-23-000033
Filing Date
2023-05-09
Accepted
2023-05-09 16:05:39
Documents
87
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q asrt-20230331.htm   iXBRL 10-Q 1145710
2 EX-31.1 exhibit311-q12023.htm EX-31.1 11138
3 EX-31.2 exhibit312-q12023.htm EX-31.2 11061
4 EX-32.1 exhibit321-q12023.htm EX-32.1 6028
5 EX-32.2 exhibit322-q12023.htm EX-32.2 6268
  Complete submission text file 0001808665-23-000033.txt   6366348

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20230331.xsd EX-101.SCH 48829
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20230331_cal.xml EX-101.CAL 72385
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20230331_def.xml EX-101.DEF 251725
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20230331_lab.xml EX-101.LAB 562441
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20230331_pre.xml EX-101.PRE 391676
81 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20230331_htm.xml XML 1030725
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

IRS No.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39294 | Film No.: 23901891
SIC: 2834 Pharmaceutical Preparations